Browsing by Author Schmoll, Hans-Joachim
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) |
|---|---|---|
| 19-Oct-2020 | Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer A Secondary Analysis of the AVANT Trial | Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez Villacampa, Mercedes; Gallego Plazas, Javier; Cervantes, Andrés; Shim, Katharine; Jonker, Derek; Guerin Meyer, Veronique; Mineur, Laurent; Banzi, Chiara; Dewdney, Alice; Dejthevaporn, Thitiya; Bloemendal, Haiko J.; Roth, Arnaud; Moehler, Markus; Aranda, Enrique; Van Cutsem, Eric; Tabernero Caturla, Josep; Schmoll, Hans-Joachim; Hoff, Paulo M.; Andre, Thierry; Gramont, Aimery de |
| 10-Sep-2012 | Cediranib with mFOLFOX6 Versus Bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: A double-blind, randomized phase II study (HORIZON III) | Schmoll, Hans-Joachim; Cunningham, David; Sobrero, Alberto; Karapetis, Christos S.; Rougier, Philippe; Koski, Sheryl L.; Kocakova, Ilona; Bondarenko, Igor; Bodoky, György; Mainwaring, Paul; Salazar Soler, Ramón; Barker, Peter; Mookerjee, Bijoyesh; Robertson, Jane; Van Cutsen, Eric |